Precision Pharmacogenetics and Genotype Class Based Prediction of Mavacamten Response in Obstructive Hypertrophic Cardiomyopathy

Conditions

• Hypertrophic Cardiomyopathy (HCM)

Interventions

• OTHER: Observational study, no new intervention offered

Sponsor

University of Manchester